Sustained clinical and commercial contracting across technologies and sites driving good growth outlook for CDMO business, ...
Laurus Labs has seen a notable increase in its consensus analyst price target, which has risen from ₹724.14 to ₹815.86. This revision follows renewed analyst optimism, attributed largely to the ...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Laurus Labs is back in focus as the latest research update resets the stock's price ...
LAURUSLABS surged on June 1. The stock opened at Rs 334.65, up over 2 per cent from its Wednesday's close of Rs 330.7 on the ...
Despite the broader market strength, Laurus Labs appears to be under pressure as CITI has maintained its ‘Sell’ rating with a ...
SUNNYVALE, Calif., May 30, 2024 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of ...
Laurus Labs has received a tentative nod from the Food and Drug Administration for Dolutegravir 5 mg and 10 mg for pediatric ARV treatment. This pediatric drug administration through oral dispersible ...
Among the likely beneficiaries, Laurus Labs and Biocon have been assigned a high probability of moving from the MSCI India ...
JM Financial anticipates significant shifts in the MSCI India Standard Index. Laurus Labs and Biocon are flagged as ...
Laurus Labs share price opened at an intraday low of ₹358.70 apiece on BSE. (AP Photo/Lo Sai Hung) According to Rajesh Bhosale, Equity Technical and Derivative Analyst at Angel One, Laurus Labs stock ...
Analysts of IIFL Capital Services recently hosted Laurus’ senior mgmt team (Dr. Satyanarayana Chava – CEO, V V Ravi Kumar – CFO, Vivek Kumar – IR) for an investor roadshow in London. While FY24 has ...
Laurus Labs Limited was originally incorporated as Laurus Labs Private Limited on September 19, 2005 at Hyderabad, Andhra Pradesh, India as a private limited company. The company was subsequently ...